Kura Oncology Expands Protection for Tipifarnib with New U.S. and European Patents

by NASDAQ Market News July 11, 2019

NASDAQ Market News
Click here to email author

Manasi Patwardhan Joins BioSig as Director of Strategic Planning

Forty Seven, Inc. and Ono Pharmaceutical Co., Ltd. Sign Regional License Agreement to Develop, Manufacture and Commercialize 5F9 in Japan, South Korea, Taiwan and Select Countries in Southeast Asia

Ads